What are the Challenges in Antibody-Based Cancer Therapies?
While antibody-based therapies hold promise, several challenges remain. One issue is the development of resistance, where cancer cells mutate and no longer express the target antigen. Another challenge is the potential for off-target effects, where antibodies may bind to normal cells, causing unintended side effects. Additionally, the cost of developing and producing monoclonal antibodies can be high, which may limit accessibility.
